Effectiveness of different treatment modalities for the management of adult-onset granulosa cell tumours of the ovary (primary and recurrent)

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 4, 2014, Pages

  Gurumurthy, Mahalakshmi ^a   Bryant, Andrew ^b   Shanbhag, Smruta ^c  

^a LLANDOUGH HOSPITAL   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CISPLATIN; ETOPOSIDE; INHIBIN A; INHIBIN B; PACLITAXEL;

ADJUVANT CHEMOTHERAPY; CANCER PROGNOSIS; CLINICAL EFFECTIVENESS; FEMALE FERTILITY; GRANULOSA CELL TUMOR; HUMAN; LYMPH NODE DISSECTION; MULTIMODALITY CANCER THERAPY; OVARY; OVERALL SURVIVAL; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RECURRENCE RISK; RECURRENT DISEASE; REVIEW; SYSTEMATIC REVIEW; ADJUVANT THERAPY; ADULT; FEMALE; META ANALYSIS; MINIMAL RESIDUAL DISEASE; MORTALITY; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDY;

ADULT; CHEMOTHERAPY, ADJUVANT; FEMALE; GRANULOSA CELL TUMOR; HUMANS; LYMPH NODE EXCISION; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES;

EID: 84901491841     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD006912.pub2     Document Type: Review

References (89)

1. Hauspy J, Beiner ME, Harley I, Rosen B, Murphy J, Chapman W, et al.Role of adjuvant radiotherapy in granulosa cell tumors of the ovary. International Journal of Radiation Oncology, Biology, Physics 2011;79(3):770-4.
2. Mangili G, Ottolina J, Gadducci A, Giorda G, Breda E, Savarese A, et al.Long-term follow-up is crucial after treatment for granulosa cell tumours of the ovary. British Journal of Cancer 2013;109:29-34. [DOI:].
3. Sun H-D, Lin H, Jao MS, Wang KL, Liou W-S, Hung Y-C, et al.A long-term follow-up study of 176 cases with adult-type ovarian granulosa cell tumors. Gynecologic Oncology 2012;124:244-9.
4. Suri A. Effects of obesity and adjuvant chemotherapy regimens on progression free survival in patients with ovarian granulosa cell tumors. Gynecologic Oncology Conference: 2013 Annual Meeting of the Western Association of Gynecologic Oncologists Seattle, WA United States. June 2013.
5. Suri A. The impact of obesity and adjuvant chemotherapy regimens on women with ovarian granulosa cell tumors. Gynecologic Oncology Conference: 44th Annual Meeting of the Society of Gynecologic Oncology Los Angeles, CA United States. March 2013.
6. Uygun K, Aydiner A, Saip P, Basaran M, Tas F, Kocak Z, et al.Granulosa cell tumor of the ovary: retrospective analysis of 45 cases. American Journal of Clinical Oncology. United States: Department of Oncology, The University of Trakya, Edirne, Turkey., 2003; Vol. 26, issue 5:517-21.
7. Al-Badawi IA, Brasher PMA, Ghatage P, Nation JG, Schepansky A, Stuart GCE. Postoperative chemotherapy in advanced ovarian granulosa cell tumors. International Journal of Gynecological Cancer. United States: Department of Gynecology, Tom Baker Cancer Center, 1331-29th Street NW, Calgary, Alberta T2N 4N2, Canada., 2002; Vol. 12, issue 1:119-23.
8. Alberti W, Bamberg M, Schulz U. Granulosa cell tumor. The results of postoperative irradiation. Deutsche Medizinische Wochenschrift (1946). GERMANY, WEST, 1984; Vol. 109, issue 19:750-2.
9. Baumann D, Donat H, Bohme M, Lenz E. Clinical experiences with treatment of granulosa cell tumors. Zentralblatt fur Gynakologie. GERMANY: Abteilung fur Gynakologische Onkologie der Klinik fur Gynakologie und Geburtshilfe, Medizinischen Akademie Magdeburg., 1992; Vol. 114, issue 7:361-4.
10. Chiara S, Merlini L, Campora E, Bruzzone M, Giudici S, Rosso R, et al.Cisplatin-based chemotherapy in recurrent or high risk ovarian granulosa-cell tumor patients. European Journal of Gynaecological Oncology 1993;14(4):314-7.
11. Colombo N, Sessa C, Landoni F, Sartori E, Pecorelli S, Mangioni C. Cisplatin, vinblastine, and bleomycin combination chemotherapy in metastatic granulosa cell tumor of the ovary. Obstetrics & Gynecology 1986;67(2):265-8.
12. Engle RB. Roentgen treatment of granulosa cell carcinoma of the ovary. American Journal of Roentgenology, Radium Therapy & Nuclear Medicine 1958;80(5):793-8.
13. Evans AT, Gaffey TA, Malkasian GD Jr, Annegers JF. Clinicopathologic review of 118 granulosa and 82 theca cell tumors. Obstetrics & Gynecology 1980;55(2):231-8.
14. Fotopoulou C, Savvatis K, Braicu EI, Brink-Spalink V, Darb-Esfahani S, Lichtenegger W, et al.Adult granulosa cell tumors of the ovary: tumor dissemination pattern at primary and recurrent situation, surgical outcome. Gynecologic Oncology November 2010;119(2):285-90.
15. Homesley HD, Bundy BN, Hurteau JA, Roth LM. Bleomycin, etoposide, and cisplatin combination therapy of ovarian granulosa cell tumors and other stromal malignancies. Gynecologic Oncology 1999;72(2):131-7.
16. Kietlińska Z, Pietrzak K, Drabik M. The management of granulosa-cell tumors of the ovary based on long-term follow up. European Journal of Gynaecologic Oncology 1993;14:118-27.
17. Nosov V, Silva I, Tavassoli F, Adamyan L, Farias-Eisner R, Schwartz PE. Predictors of recurrence of ovarian granulosa cell tumors. International Journal of Gynecologic Cancer 2009;19(4):628-33.
18. Pankratz E, Boyes DA, White GW, Galliford BW, Fairey RN, Benedet JL. Granulosa cell tumors. A clinical review of 61 cases. Obstetrics and Gynecology. UNITED STATES, 1978; Vol. 52, issue 6:718-23.
19. Pautier P, Gutierrez-Bonnaire M, Rey A, Sillet-Bach I, Chevreau C, Kerbrat P, et al.Combination of bleomycin, etoposide, and cisplatin for the treatment of advanced ovarian granulosa cell tumors. International Journal of Gynecologic Cancer 2008;18(3):446-52.
20. Pecorelli S, Wagenaar HC, Vergote IB, Curran D, Beex LV, Wiltshaw E, et al.Cisplatin (P), vinblastine (V) and bleomycin (B) combination chemotherapy in recurrent or advanced granulosa(-theca) cell tumours of the ovary. European Journal of Cancer 1999;35(9):1331-7.
21. Pectasides D, Alevizakos N, Athanassiou AE. Cisplatin-containing regimen in advanced or recurrent granulosa cell tumours of the ovary. Annals of Oncology 1992;3(4):316-8.
22. Savage P, Constenla D, Fisher C, Shepherd JH, Barton DP, Blake P, et al.Granulosa cell tumours of the ovary: demographics, survival and the management of advanced disease. Clinical Oncology (Royal College of Radiology) 1998;10(4):242-5.
23. Sehouli J, Drescher FS, Mustea A, Elling D, Friedmann W, Kühn W, et al.Granulosa cell tumor of the ovary: 10 years follow-up data of 65 patients. Anticancer Research 2004;24(2C):1223-9.
24. Tao X, Sood AK, Deavers MT, Schmeler KM, Nick AM, Coleman RL, et al.Anti-angiogenesis therapy with bevacizumab for patients with ovarian granulosa cell tumors. Gynecologic Oncology. United States: Department of Gynecologic Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030-1439, USA., 2009; Vol. 114, issue 3:431-6.
25. Wolf JK, Mullen J, Eifel PJ, Burke TW, Levenback C, Gershenson DM. Radiation treatment of advanced or recurrent granulosa cell tumor of the ovary. Gynecologic Oncology 1999;73(1):35-41.
26. Zambetti M, Escobedo A, Pilotti S, De Palo G. Cis-platinum/vinblastine/bleomycin combination chemotherapy in advanced or recurrent granulosa cell tumors of the ovary. Gynecologic Oncology. UNITED STATES: Division of Medical Oncology, Institute Nazionale Tumori, Milan, Italy., 1990; Vol. 36, issue 3:317-20.
27. Van LL (Principal investigator). Paclitaxel in treating patients with ovarian stromal cancer. http://clinicaltrials.gov/show/NCT00006227.
28. Brown J. Paclitaxel and carboplatin or bleomycin sulfate, etoposide phosphate, and cisplatin in treating patients with advanced or recurrent sex cord-ovarian stromal tumors. http://clinicaltrials.gov/show/NCT01042522.
29. Garcia-Donas J (Study Director). Ketoconazole as inhibitor of the enzyme CYP17 in locally advanced or disseminated granulosa cell tumour of ovary. http://clinicaltrials.gov/show/NCT01584297.
30. Aboud E. Adult granulosa cell tumours of the ovary. European Journal of Gynaecological Oncology 1997;XVIII(6):520-2.
31. Abu-Rustum N, Restivo A, Ivy J, Soslow R, Sabbatini P, Sonoda Y, et al.Retroperitoneal nodal metastasis in primary and recurrent granulosa cell tumours of the ovary. Gynecologic Oncology 2006;103:31-4.
32. Ameryckx L, Fatemi H, De Sutter P, Amy J. GnRH antagonist in the adjuvant treatment of a recurrent ovarian granulosa cell tumor: a case report. Gynecologic Oncology 2005;99(3):764-6.
33. Ayhan A, Salman M, Velipasaoglu M, Sakinci M, Yuce K. Prognostic factors in adult granulosa cell tumors of the ovary: a retrospective analysis of 80 cases. Journal of Gynecologic Oncology 2009;20(3):158-63.
34. Benedet JL, Bender H, Jones H 3rd, Ngan HY, Pecorelli S. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. International Journal of Gynaecology and Obstetrics 2000;70(2):209-62.
35. Boggess JF, Soules MR, Goff BA, Greer BE, Cain JM, Tamimi HK. Serum inhibin and disease status in women with ovarian granulosa cell tumors. Gynecologic Oncology 1997;64:64-9.
36. Briasoulis E, Karavasilis V, Pavlidids N. Megestrol activity in recurrent adult type granulosa cell tumour of the ovary. Annals of Oncology 1997;8:811-2.
37. Brown J, Shvartsman H, Deavers M, Burke T, Munsell M, Gershenson D. The activity of taxanes in the treatment of sex cord-stromal tumors. Journal of Clinical Oncology 2004;22(17):3517-23.
38. Brown J, Shvartsman H, Deavers M, Ramondetta L, Burke T, Munsell M, et al.The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cord-stromal ovarian tumours. Gynecologic Oncology 2005;97(2):489-96.
39. Choan E, Samant R, Kee Fung M, Le T, Hopkins L, Senterman M. Palliative radiotherapy for recurrent granulosa cell tumour of the ovary: a report of 3 cases with radiological evidence of response. Gynecologic Oncology 2006;102:406-10.
40. Colombo N, Sessa C, Landoni F, Sartori E, Pecorelli S, Mangioni C. Cisplatin, vinblastine, and bleomycin combination chemotherapy in metastatic granulosa cell tumor of the ovary. Obstetrics and Gynecology 1986;67:265-8.
41. Colombo N, Parma G, Franchi D. An active chemotherapy regimen for advanced ovarian sex cord-stromal tumours. Gynecologic Oncology 1999; Vol. 72:129-30.
42. Colombo N, Parma G, Zanagnolo V, Insinga A. Management of ovarian stromal cell tumors. Journal of Clinical Oncology 2007;25(20):2944-51.
43. Cornis R, Group Chair Eastern Cooperative Oncology Group (ECOG). ECOG common toxicity criteria. http://www.ecog.org/general/common_tox.html (accessed March 2014).
44. National Institutes of Health: National Cancer Institute. Common terminology criteria for adverse events v4.03: June 14, 2010. http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference:5x7.pdf.
45. D'Angelo E, Mozos A, Nakayama D, Espinosa I, Catasus L, Prat J, et al.Prognostic significance of FOXL2 mutation and mRNA expression in adult and juvenile granulosa cell tumors of the ovary. Modern Pathology 2011;24(10):1360-7.
46. Deeks J, Altman D, Bradburn M. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Davey Smith G, Altman D editor(s). Systematic Reviews in Health Care: Meta-analysis in Context. 2nd Edition. London: BMJ Publishing Group, 2001.
47. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7:177-88.
48. Disaia P, Saltz A, Kagan A, Rich W. A temporary response of recurrent granulosa cell tumor to adriamycin. Obstetrics and Gynecology 1978;52:355-8.
49. Fishman A, Kudelka A, Tresukosol D, Edwards C, Freedman R, Kaplan A, et al.Leuprolide acetate for treating refractory or persistent ovarian granulosa cell tumor. Journal of Reproductive Medicine 1996;41(6):393-6.
50. Fox H, Agrawal K, Langley F. A clinicopathologic study of 92 cases of granulosa cell tumours of the ovary with special reference to the factors affecting prognosis. Cancer 1975;35:231.
51. Fox H, Buckley C. Pathology of malignant gonadal stromal tumours of ovary. In: Coppleson M editor(s). Gynaecologic Oncology. Vol. 59, Edinburgh: Churchill Livingstone, 1992:947.
52. Freeman S, Modesitt S. Anastrozole therapy in recurrent adult granulosa cell tumors: a report of 2 cases. Gynecologic Oncology 2006;103(2):755-8.
53. Geerts I, Vergote I, Neven P, Billen J. The role of Inhibins B and antimullerian hormone for diagnosis and follow-up of granulosa cell tumors. International Journal of Gynecological Cancer 2009;19(5):847-55.
54. Gershenson D, Copeland L, Kavanagh J, Stringer C, Saul P, Wharton J. Treatment of metastatic stromal tumors of the ovary with cisplatin, doxorubicin and cyclophosphamide. Obstetrics and Gynecology 1987;70:765-9.
55. Gershenson D, Morris M, Burke T, Levenback C, Matthews C, Wharton J. Treatment of poor prognosis sex-cord stromal tumors of the ovary with the combination of bleomycin, etoposide and cisplatin. Obstetrics and Gynecology 1996;87:527-31.
56. Gershenson D, McGuire W, Gore M, Quinn M, Thomas G. Gynaecologic Cancers: Controversies in Management. Philadelphia, PA: Elsevier, 2004.
57. GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ 2004;328:1490-4.
58. Haba R, Miki H, Kobayashi S, Ohmori M. Combined analysis of flow cytometry and morphometry of ovarian granulosa cell tumor. Cancer 1993;72:3258-62.
59. Hardy R, Bell J, Nicely C, Reid G. Hormonal treatment of a recurrent granulosa cell tumor of the ovary: case report and review of literature. Gynecologic Oncology 2005;96:865-9.
60. Higgins J, Thompson S, Deeks J, Altman D. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
61. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane-handbook.org.
62. Homesley H, Bundy B, Hurteau J, Roth L. Bleomycin, etoposide, and cisplatin combination therapy of ovarian granulosa cell tumors and other stromal malignancies: a Gynecologic Oncology Group study. Gynecologic Oncology 1999;2(72):131-7.
63. Hoskins W, Rubin S. Malignant gonadal stromal tumours of ovary: clinical features and management. In: Coppleson M editor(s). Gynaecologic Oncology. Vol. 60, Edinburgh: Churchill Livingstone, 1992:961.
64. Jacobs A, Deppe G, Cohen C. Combination chemotherapy of ovarian granulosa cell tumor with cis-platinum and doxorubicin. Gynecologic Oncology 1982;14:294-7.
65. Jamieson S, Butzow R, Andersson N, Alexiadis M, Unkila-Kallio L, Anttonen M, et al.The FOXL2 C134W mutation is characteristic of adult granulosa cell tumors of the ovary. Modern Pathology 2010;23(11):1477-85.
66. Kauppila A, Bangah M, Burger H, Martikainen H. GnRH agonist analog therapy in advanced/ recurrent granulosa cell tumors: further evidence of a role of inhibin in monitoring response to treatment. Gynecologic Endocrinology 1992;6(4):271-4.
67. Kim YM, Jung M, Kim K, Kim YT, Nam J, Mok J. Adult granulosa cell tumor of the ovary: 35 cases in a single Korean institute. Acta Obstetrica et Gynecologica 2006;85:112-5.
68. Korach J, Tamar P, Mario B, Tima D, Eddie F, Gilad B. Promising effect of aromatase inhibitors on recurrent granulosa cell tumors. International Journal of Gynecological Cancer 2009;19(5):830-3.
69. Lee I, Levin W, Chapman W, Goldberg R, Murphy K, Milosevic M. Radiotherapy for the treatment of metastatic granulosa cell tumor in the mediastinum: a case report. Gynecologic Oncology 1999;73:455-60.
70. Liu J, Hyden-Granskog C, Voutilainen R. Gonadotrophins inhibit and activin induces expression of inhibin/ activin beta subunit mRNA in cultured human granulosa-luteal cells. Molecular Human Reproduction 2001;7(4):319-23.
71. Lovell T, Gladwell R, Groome N, Knight P. Modulatory effects of gonadotrophins and insulin-like growth factor on the secretion of inhibin A and progesterone by granulosa cells from chicken preovulatory (F1-F3) follicles. Reproduction 2002;123(2):291-300.
72. Malmstrom H, Hogberg T, Risberg B, Simonsen E. Granulosa cell tumors of the ovary: prognostic factors and outcome. Gynecologic Oncology 1994;52:50-5.
73. Martikainen H, Penttinen J, Huhtaniemi I, Kauppila A. Gonadotropin-releasing hormone analog therapy effective in ovarian granulosa cell malignancy. Gynecologic Oncology 1989;35(3):406-8.
74. Maxwell G, Soisson A, Miles P. Failure of gonadotropin releasing hormone therapy in patients with metastatic ovarian sex cord stromal tumors. Oncology 1994;51(4):356-9.
75. Miller A, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981;47:207-14.
76. Mom CH, Engelen MJA, Willemse PHB, Gietema GA, Ten Hoor KA, De Vries EG, et al.Granulosa cell tumors of the ovary: the clinical value of serum inhibin A and B levels in a large single center cohort. Gynecologic Oncology 2007;2:365-72.
77. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp (accessed March 2014).
78. Ohel G, Kaneti H, Schenker J. Granulosa cell tumors in Israel: a study of 172 cases. Gynecologic Oncology 1983;15:278-86.
79. Park JY, Jin KL, Kim DY, Kim JH, Kim YM, et al.Surgical staging and adjuvant chemotherapy in the management of patients with adult granulosa cell tumors of the ovary. Gynecologic Oncology 2012;125(1):80-6.
80. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer Incidence in Five Continents, vol VIII. IARC Scientific Publication No. 155. Vol. CD-ROM C15 I-VIII: updated database, Lyon, France: International Agency for Research on Cancer, 2003.
81. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17:2815-34.
82. Rao G, Miller D. Clinical applications of hormonal therapy in ovarian cancer. Current Treatment Options in Oncology 2005;6(2):97-102.
83. Savage P, Constenla D, Fisher C, Shepherd J, Barton D, Blake P, et al.Granulosa cell tumors of the ovary: demographics, survival and the management of advanced disease. Clinical Oncology 1998;10:242-5.
84. Schumer S, Cannistra S. Granulosa cell tumour of the ovary. Journal of Clinical Oncology 2003;21(6):1180-9.
85. Stuart G, Dawson L. Update on granulosa cell tumours of the ovary. Current Opinion in Obstetrics and Gynecology 2003;15(1):33-7.
86. Taggart DP, D'Amico R, Altman DG. Effect of arterial revascularisation on survival: a systematic review of studies comparing bilateral and single internal mammary arteries. The Lancet 2001;358:870-5.
87. Thrall MM, Paley P, Pizer E, Garcia R, Goff BA. Patterns of spread and recurrence of sex cord-stromal tumors of the ovary. Gynecologic Oncology 2011;122(2):242-5.
88. Tresukosol D, Kudelka A, Edwards C, Charnsangavej C, Narboni N, Kavanagh J. Recurrent ovarian granulosa cell tumor: a case report of a dramatic response to Taxol. International Journal of Gynecological Cancer 1995;5:156-9.
89. Wolf J, Mullen J, Eifel P, Burke T, Levenback C, Gerhenson D. Radiation treatment of advanced or recurrent granulosa cell tumor of the ovary. Gynecologic Oncology 1999;73:35-41.